thiazoles has been researched along with Neoplasms, Squamous Cell in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carlton, MM; Dirksen, WP; Hildreth, BE; Lanigan, LG; London, CA; Martin, CK; Pillai, SP; Rosol, TJ; Simmons, JK; Toribio, RE; Werbeck, JL | 1 |
| Bai, Y; Chen, YA; Fang, B; Fisher, K; Haura, EB; Kim, JY; Kinose, F; Koomen, JM; Rix, U; Song, L; Teer, JK; Watters, JM | 1 |
| Dunn, EF; Iida, M; Li, C; Wheeler, DL | 1 |
| Chinn, SB; Hochstim, C; Masood, R; Schorn, VJ; Sinha, UK; Zhu, S | 1 |
4 other study(ies) available for thiazoles and Neoplasms, Squamous Cell
| Article | Year |
|---|---|
Combined zoledronic acid and meloxicam reduced bone loss and tumour growth in an orthotopic mouse model of bone-invasive oral squamous cell carcinoma.
Topics: Analysis of Variance; Animals; Antineoplastic Combined Chemotherapy Protocols; Bone Density Conservation Agents; Bone Neoplasms; Bone Resorption; Cat Diseases; Cats; Cell Line, Tumor; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Diphosphonates; Disease Models, Animal; Heterografts; Humans; Imidazoles; Male; Meloxicam; Mice; Mice, Nude; Mouth Neoplasms; Neoplasms, Squamous Cell; Random Allocation; Real-Time Polymerase Chain Reaction; RNA, Messenger; Thiazines; Thiazoles; Treatment Outcome; Zoledronic Acid | 2015 |
Adaptive responses to dasatinib-treated lung squamous cell cancer cells harboring DDR2 mutations.
Topics: Adaptive Immunity; Apoptosis; Cell Line, Tumor; Dasatinib; Discoidin Domain Receptors; Drug Resistance, Neoplasm; Drug Synergism; Humans; Lung Neoplasms; Mutation; Neoplasms, Squamous Cell; Proto-Oncogene Proteins c-ret; Pyrimidines; Receptor Protein-Tyrosine Kinases; Receptors, Mitogen; Receptors, Somatomedin; Signal Transduction; Thiazoles | 2014 |
Dasatinib blocks cetuximab- and radiation-induced nuclear translocation of the epidermal growth factor receptor in head and neck squamous cell carcinoma.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Carcinoma; Carcinoma, Squamous Cell; Cell Line, Tumor; Cetuximab; Dasatinib; ErbB Receptors; Head and Neck Neoplasms; Humans; Neoplasms, Squamous Cell; Protein Kinase Inhibitors; Protein Transport; Pyrimidines; Squamous Cell Carcinoma of Head and Neck; Thiazoles | 2010 |
Increased radiation sensitivity of head and neck squamous cell carcinoma with sphingosine kinase 1 inhibition.
Topics: Animals; Apoptosis; Blotting, Western; Carcinoma; Carcinoma, Squamous Cell; Disease Models, Animal; Enzyme Inhibitors; Head and Neck Neoplasms; Humans; Immunohistochemistry; In Vitro Techniques; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms, Squamous Cell; Phosphotransferases (Alcohol Group Acceptor); Polymerase Chain Reaction; Radiation Tolerance; Squamous Cell Carcinoma of Head and Neck; Thiazoles; Treatment Outcome | 2011 |